US$ 25.01
ghk-cu injection clinical trial safety The tri-peptide complex ameliorates lipopolysaccharide-induced acute lung injury in mice GHK-Cu Peptide Injection Before and
Description
At 8 mg and 12 mg, the results were dramatic, with the highest dose producing an average 24.2% body weight reduction over 48 weeks

Mitochondrial SIRT3 as a protective factor against cyclosporine A-induced nephrotoxicity

The Lipotropic and Vitamin B12 injections contain a proprietary combination of the following: Choline An amino acid that supports the health of the liver in its processing and excretion of chemical waste products within the body

These attributes include ease of modification, sustained release, active targeting, and low side effects

Sold for Research Use Only / Not FDA Regulated Batch-verified inventory

Water (Aqua), Copper Tripeptide-1 (GHK-Cu) 1%, Phenoxyethanol (and) Ethylhexylglycerin
